Dr. Solomon's research interests include novel approaches to treating leukemia, lymphoma, and myeloma. More specifically, his work has focused on the role of allogeneic and autologous immune system modulation to treat various blood cancers. Past and current trials evaluate the role of haploidentical transplantation, CAR-T therapy, immune checkpoint inhibitors and adoptive immunotherapy. In addition, another clinical interest involves improving the success of allogeneic stem cell transplantation, with an emphasis on developing novel graft-versus-host disease (GVHD) prevention and treatment strategies.

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Bristol Myers Squibb
Jazz Pharmaceuticals
AbbVie
Genentech
Amgen

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

https://www.guidestar.org/profile/45-5354811